Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001213900-25-001165
Filing Date
2025-01-06
Accepted
2025-01-06 16:10:08
Documents
1
Period of Report
2025-01-02

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 3394
  Complete submission text file 0001213900-25-001165.txt   5002
Mailing Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036
Business Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036 646-844-1164
ORAMED PHARMACEUTICALS INC. (Issuer) CIK: 0001176309 (see all company filings)

EIN.: 980376008 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 20 MAMILLA AVENUE JERUSALEM L3 9414904
Business Address
Hexter Joshua (Reporting) CIK: 0001573235 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35813 | Film No.: 25511161